Phase IIb Primary Vaccination Study to Evaluate Non-Inferiority & Persistence of the Immune Response of GSK Biologicals' MenACWY Conjugate Vaccine (Intramuscularly) vs Mencevax ACWY (Subcutaneously) to Healthy Subjects (11-55 Years of Age)
2020-07-04
عنوان الدراسة
Phase IIb Primary Vaccination Study to Evaluate Non-Inferiority & Persistence of the Immune Response of GSK Biologicals' MenACWY Conjugate Vaccine (Intramuscularly) vs Mencevax ACWY (Subcutaneously) to Healthy Subjects (11-55 Years of Age)
داعم الدراسة
Gsk
دواء الدراسة
Meningococcal ACWY Conjugate Vaccine
رقم بروتوكول الدراسة
107402
حالة الدراسة
Completed
موقع الدراسة
King Abdulaziz Medical City NG (Riyadh)
مرحلة الدراسة
3b
Comments and Suggestions
For any inquiries or comments about the government services, please fill in the required information.